All Articles

In a rural California town, a new solar project is delivering more than clean power. It's building a lifeline—a permanent, state-of-the-art fire station.

A Canadian upstart is poised to unlock a massive, untreated market by moving glaucoma surgery from the OR to the office. This isn't just a new device; it's a strategic dismantling of a decades-old bottleneck.

With 80% of trials delayed, the life sciences industry is gathering to tackle its patient enrollment crisis. Can new partnerships and AI finally move the needle?

Altera's Agilex 9 FPGA packs RF, compute, and memory into one chip, promising a leap in performance for defense, aerospace, and next-gen communications.

MAX Power is shedding its lithium asset to go all-in on natural hydrogen. A look at the strategic choice that splits the energy transition in two.

A digital health firm is trading millions in shares for a spot on the racetrack. A deep dive into the high-octane strategy to solve healthcare access.

A new report reveals a dangerous disconnect: while AI accelerates coding, 95% of CISOs are pressured to ignore the security flaws it creates.

Hilton Hawaiian Village's legendary Rainbow Tower gets a modern, art-infused refresh, blending 65 years of history with a strategic vision for the future.

Good Grains' nationwide launch in Sprouts isn't just another product release. It's a signal of the food industry's pivot toward transparency and resilience.

K-beauty leader Rael disrupts the U.S. market with advanced hydrogel masks and the first Korean-made tampon, pioneering a new era of 'K-Wellness'.

Luxardo's new Decaf Espresso Liqueur isn't just a new bottle. It's a strategic move to capture the mindful drinking trend and dominate the espresso martini scene.

New research shows 'Food is Medicine' programs thrive when paired with human coaching, offering a potent, scalable model for tackling chronic disease.

Melcor Developments is betting on itself with a massive share buyback. Is it a savvy move to exploit an undervalued stock or a bold signal of confidence?

BioCardia secures a crucial $4.4M, extending its runway for a key Japan submission. But a closer look reveals a high-stakes bet on future warrant exercises.

As return-to-office mandates clash with the needs of 5 million Canadians with migraine, the economic toll of inaction is mounting for employers.

As outdoor recreation booms, volunteer Search & Rescue teams are stretched thin. A unique corporate pledge offers a sustainable model to fund these vital services.

Eikon Therapeutics adds a consumer goods giant to its board, a move signaling a strategic pivot from pure science to global commercialization.

As autonomous AI agents enter the enterprise, a critical 'proof gap' emerges. Ares Networks' new platform on Microsoft Azure uses blockchain to close it.

The AvalonBay-Equity merger just named its leaders. It's not just a new C-suite; it's a blueprint for a tech-driven, $69B titan set on dominating the rental market.

The promotion of Tony Pallas to CTO is no mere shuffle. It's a calculated move to arm thousands of franchisees with AI, signaling a new front in the war for hospitality tech dominance.